ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 660,01
0,26%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV
  6. Neovasc Inc. (NVC)

  7. Neovasc Inc. (NVC) Actualités

NVC

Neovasc Inc. (NVC)

Neovasc Inc.
De:
Trier par:
 Showing the most relevant articles for your search:TSXV:NVC
DateHeureSourceTitreSymboleSociété
20/06/201413h00PR Newswire (Canada)Neovasc Inc. Announces Receipt of Final Approval to Graduate to the TSXTSXV:NVCNeovasc Inc.
19/06/201413h00PR Newswire (Canada)Neovasc Inc. reports results of Annual General Meeting of ShareholdersTSXV:NVCNeovasc Inc.
12/06/201420h18PR Newswire (Canada)Neovasc earns a spot in 2014 PROFIT 500 ListTSXV:NVCNeovasc Inc.
06/06/201422h15PR Newswire (Canada)Neovasc Inc. provides initial comments on lawsuitTSXV:NVCNeovasc Inc.
22/05/201413h00PR Newswire (Canada)Neovasc Inc. reports financial results for first quarter 2014TSXV:NVCNeovasc Inc.
21/05/201416h45PR Newswire (Canada)Positive First-In-Human Experience With Neovasc's Tiara™ Transcatheter Mitral Valve Presented at EuroPCR 2014TSXV:NVCNeovasc Inc.
16/05/201413h00PR Newswire (Canada)Neovasc Inc. to begin trading on the NASDAQ Capital MarketTSXV:NVCNeovasc Inc.
13/05/201413h00PR Newswire (Canada)Neovasc Inc. Announces Upcoming Presentations at EuroPCR 2014TSXV:NVCNeovasc Inc.
08/05/201413h00PR Newswire (Canada)Neovasc Hires Industry Veteran Vicki Bebeau as Vice President, Clinical AffairsTSXV:NVCNeovasc Inc.
18/04/201400h17PR Newswire (Canada)Neovasc announces filing of shelf prospectus and application to list on NASDAQTSXV:NVCNeovasc Inc.
17/04/201413h00PR Newswire (Canada)Neovasc Inc. Reports Financial Results For 2013TSXV:NVCNeovasc Inc.
31/03/201413h00PR Newswire (Canada)COSIRA Study Data Presented at ACC.14 Confirms the Neovasc Reducer(TM) Improves Functional Capabilities in Refractory Angina ...TSXV:NVCNeovasc Inc.
26/03/201414h24Marketwired CanadaNeovasc Inc. Closes C$25 Million Bought Deal Equity FinancingTSXV:NVCNeovasc Inc.
17/03/201412h00PR Newswire (Canada)Neovasc Reducer™ for Refractory Angina Featured in Live Case Session at 10th Annual Congress of Update in Cardiology and Ca...TSXV:NVCNeovasc Inc.
04/03/201413h00PR Newswire (Canada)Neovasc Inc. Provides Update on Tiara™ Transcatheter Mitral Valve and Reducer™ ProgramsTSXV:NVCNeovasc Inc.
03/03/201421h42Marketwired CanadaNeovasc Announces C$25,152,000 Bought Deal Equity FinancingTSXV:NVCNeovasc Inc.
03/02/201413h15PR Newswire (Canada)Neovasc Inc. Announces Successful First Human Implant of Tiara™ Transcatheter Mitral ValveTSXV:NVCNeovasc Inc.
20/11/201313h28PR Newswire (Canada)Neovasc Inc. Reports Financial Results for Third Quarter of 2013TSXV:NVCNeovasc Inc.
13/11/201313h28PR Newswire (Canada)Neovasc receives first US patent for its novel Tiara(TM) transcatheter mitral valve replacement technologyTSXV:NVCNeovasc Inc.
06/11/201313h28PR Newswire (Canada)Neovasc Reducer™ Achieves Primary Endpoint in COSIRA Trial, Significantly Improving Functional Capabilities in Patients wit...TSXV:NVCNeovasc Inc.
29/10/201312h28PR Newswire (Canada)Neovasc Inc. Announces Publication of Positive Tiara™ Preclinical Data in the Journal JACC: Cardiovascular InterventionsTSXV:NVCNeovasc Inc.
24/10/201313h28PR Newswire (Canada)Neovasc Inc. announces upcoming presentations at TCT 2013 scientific symposiumTSXV:NVCNeovasc Inc.
15/08/201313h28PR Newswire (Canada)Neovasc Inc. reports financial results for second quarter of 2013TSXV:NVCNeovasc Inc.
28/05/201313h30PR Newswire (Canada)Neovasc Inc. Reports Financial Results for First Quarter of 2013TSXV:NVCNeovasc Inc.
23/05/201313h30PR Newswire (Canada)Positive Animal Data Presented at EuroPCR Sets Stage for Advancing Neovasc's Tiara(TM) Transcatheter Mitral Valve into Human ...TSXV:NVCNeovasc Inc.
21/05/201313h30PR Newswire (Canada)Registry Data Presented at EuroPCR 2013 Confirms the Neovasc Reducer™ Improves Cardiovascular Parameters in Refractory Angi...TSXV:NVCNeovasc Inc.
13/05/201313h25PR Newswire (Canada)Neovasc Inc. Completes Enrollment in COSIRA Trial Assessing Efficacy of Reducer™ Product for Treatment of Refractory AnginaTSXV:NVCNeovasc Inc.
29/04/201313h25PR Newswire (Canada)Neovasc Inc. reports financial results for 2012 year-endTSXV:NVCNeovasc Inc.
25/04/201313h30PR Newswire (Canada)Neovasc Inc. reports exercise of 1.8 million warrants for net proceeds of $2.3 millionTSXV:NVCNeovasc Inc.
28/02/201313h30PR Newswire (Canada)Neovasc's COSIRA clinical trial protocol selected for publication in peer-reviewed journalTSXV:NVCNeovasc Inc.
 Showing the most relevant articles for your search:TSXV:NVC

Dernières Valeurs Consultées

EU
AI
Air Liquide
SPI
SP500
S&P 500
EU
SGO
Cie de SaintGobain
EU
BN
Danone
NASDAQ
GOOGL
Alphabet
EU
PX4
SBF 120
FTSE
UKX
FTSE 100
EU
DG
Vinci
COIN
BTCUSD
Bitcoin
NASDAQ
AMZN
Amazon.com
EU
BNP
BNP Paribas
NASDAQ
AAPL
Apple
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés